The UN-backed Covax scheme, which aims to provide vaccine doses to low and middle-income countries, has agreed to a deal with drugmaker Moderna to supply up to 500 million doses, APA reports citing BBC.
The advance purchased agreement, announced on Monday, will see 34m doses available towards the end of this year with the bulk available in 2022.
In a statement, the US drugmaker said the doses would be offered at its "lowest tiered price".
The deal comes days after the US drugmaker's jab was given emergency use listing by the World Health Organization (WHO).
The WHO has repeatedly urged wealthier nations to share vaccine supplies around the world. On Monday, Sweden said it would donate 1 million doses of AstraZeneca to the initiative.